I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded-End Point Evaluation Study

Clinical Therapeutics

Volumn 34, Issue 8, 2012, Pages 1705-1719

  Bobrie, Guillaume ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Angiotensin II receptor antagonists; Home blood pressure monitoring; Irbesartan amlodipine; Self blood pressure measurement

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS IRBESARTAN; HYPERTENSIVE AGENT; IRBESARTAN; UNCLASSIFIED DRUG;

ACUTE CHOLECYSTITIS; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHENIA; BLOOD PRESSURE MONITORING; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; HEPATOBILIARY DISEASE; HUMAN; INDUCED HYPOTENSION; KIDNEY CYST; KIDNEY DISEASE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; MYALGIA; NEUROLOGIC DISEASE; PERIPHERAL EDEMA; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT OUTCOME; URINARY TRACT DISEASE; VASCULAR DISEASE;

ADULT; AFRICA, NORTHERN; AGED; AGED, 80 AND OVER; AMLODIPINE; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; LEBANON; MALE; MEXICO; MIDDLE AGED; PROSPECTIVE STUDIES; SAUDI ARABIA; SOUTH AMERICA; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864620981     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2012.06.026     Document Type: Article

References (25)

1. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
2. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535. Blood Pressure Lowering Treatment Trialists' Collaboration.
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713. UK Prospective Diabetes Study Group.
4. Wang J.G., Staessen J.A., Franklin S.S., et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005, 45:907-913.
5. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338:b1665.
6. Sica D.A. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002, 62:443-462.
7. Weber M.A. Creating a combination antihypertensive regimen: what does the research show?. J Clin Hypertens 2003, 5(Suppl 3):12-20.
8. Morgan T., Anderson A. A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension. Am J Hypertens 2002, 15:544-549.
9. Allemann Y., Fraile B., Lambert M., et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens 2008, 10:185-194.
10. Chrysant S.G., Melino M., Karki S., et al. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 2008, 30:587-604.
11. Hypertension: the clinical management of primary hypertension in adults. CG127/NICE Guideline. National Clinical Guideline Centre August 2011, NICE.
12. Fogari R., Zoppi A., Derosa G., et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007, 21:220-224.
13. Croom K.F., Curran M.P., Goa K.L., Perry C.M. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs 2004, 64:999-1028.
14. Haria M., Wagstaff A.J. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs 1995, 50:560-586.
15. Epstein B.J., Vogel K., Palmer B.F. Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs 2007, 67:1309-1327.
16. Cockroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
17. O'Brien E., Pickering T., Asmar R., et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002, 7:3-17.
18. Smith T.R., Philipp T., Vaisse B. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens 2007, 9:355-364.
19. Philipp T., Smith T.R., Glazer R. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007, 29:563-580.
20. Flack J.M., Calhoun D.A., Satlin L., et al. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. J Hum Hypertens 2009, 23:479-489.
21. Fogari R., Zoppi A., Mugellini A., et al. Efficacy and safety of two treatment combinations of hypertension in very elderly patients. Arch Gerontol Geriatr 2009, 48:401-405.
22. Calhoun D.A., Lacourcière Y., Chiang Y.T., Glazer R.D. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension 2009, 54:32-39.
23. Oparil S., Giles T., Ofili E.O., et al. Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy. J Hypertens 2011, 29:161-170.
24. Wald D.S., Law M., Morris J.K., et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009, 122:290-300.
25. Pimenta E., Oparil S. Fixed combinations in the management of hypertension: patients perspectives and rationale for development and utility of the olmesartan-amlodipine combination. Vasc Health Risk Manag 2008, 4:653-664.